CUBE vs SRPT · P/E 25, rev $1.07B vs rev $1.90B
CubeSmart (CUBE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CUBE and SRPT stock pages for the full models.
Not investment advice.